Financial Snapshot

This section of the Fusion Pharmaceuticals InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Fusion Pharmaceuticals assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQFUSN
Beta0.19
Shares Outstanding43.0M
Average Volume (10 days)10.9K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.61)
Sales (TTM)$0.01
Book Value (MRQ)$6.13
Cash Flow (TTM)($1.28)
Cash (MRQ)$4.20

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy5
 
Buy1
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Steven Gannon
Director
2,829
Buy
Aug 23, 2021
Steven Gannon
Director
3,000
Buy
Aug 19, 2021
Steven Gannon
Director
171
Buy
Aug 18, 2021
Steven Gannon
Director
6,000
Buy
Aug 16, 2021
Heather Preston
Director
8,823
Buy
Jun 30, 2020

Recent SEC Filings

New Insider
Sep 30, 2021
Insider Buy/Sell
Sep 30, 2021
Insider Buy/Sell
Aug 23, 2021
Insider Buy/Sell
Aug 20, 2021
Insider Buy/Sell
Aug 17, 2021
NEVER MISS AN UPDATE